Phototherapy Combination With Topicals in Vitiligo
- Conditions
- Vitiligo, Generalized
- Interventions
- Combination Product: Tacrolimus 0.1% ointment twice daily plus NBUVB 3 times weeklyCombination Product: Calcipotriol/Betamethasone ointment plus NBUVB
- Registration Number
- NCT04440371
- Lead Sponsor
- Jordan University of Science and Technology
- Brief Summary
Patients will be included in a randomized controlled clinical trial, will enroll only adult vitiligo patients with surface area of at least 10% who are being followed in the outpatient dermatology clinics of King Abdullah University Hospital (KAUH) and are planned to start on phototherapy Narrow Band Ultraviolet light B (NBUVB), regardless if they have previous treatment for their disease, one month wash off period will be given for patients who are already on phototherapy or other treatments for vitiligo.
- Detailed Description
Patients to be included in this randomized controlled study are adults with generalized vitiligo of surface area of at least 10% who are being followed in the outpatient dermatology clinics of King Abdullah University Hospital (KAUH) and are planned to start on phototherapy Narrow Band Ultraviolet light B (NB-UVB), regardless if they have previous treatment for their disease, one month wash off period will be given for patients who are already on phototherapy or other treatments for vitiligo. In our going study, adult patients will be enrolled into 2 groups ( around 20 patients per each) in which NBUVB will be given 2-3 sessions per week in combination with one of the following randomly; one group will start on Tacrolimus 0.1% ointment twice daily, a second group will start on calcipotriol \& betamethasone containing cream once daily, photos will be taken and the exact sites involved will be detected, efficacy of treatment will be assessed according to repigmentation percentages of vitiligo areas from baseline at 3 and 6 months. The improvement at 6 months compared to baseline will be classified into 5 groups according to the percentage of repigmentation as follow; excellent (76%-100%); moderate (51%-75%); mild (26%-50%); minimal (1%-25%); or no response.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 40
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Tacrolimus Calcipotriol/Betamethasone ointment plus NBUVB Phototherapy NBUVB will be given 3 times per week and Tacrolimus 0.1% ointment will be applied twice a day calcipotriol / betamethasone Calcipotriol/Betamethasone ointment plus NBUVB Phototherapy NBUVB will be given 3 times per week and calcipotriol \& betamethasone containing cream will be applied once a day Tacrolimus Tacrolimus 0.1% ointment twice daily plus NBUVB 3 times weekly Phototherapy NBUVB will be given 3 times per week and Tacrolimus 0.1% ointment will be applied twice a day calcipotriol / betamethasone Tacrolimus 0.1% ointment twice daily plus NBUVB 3 times weekly Phototherapy NBUVB will be given 3 times per week and calcipotriol \& betamethasone containing cream will be applied once a day
- Primary Outcome Measures
Name Time Method efficacy of treatment Baseline: measurement of vitiligo BSA with photographs of vitiligo areas. lab investigations done at this stage The area of vitiligo will be measured using body surface area (BSA) at baseline. the difference in BSA will represent the improvement from baseline. Patient palm will be used for estimation of BSA at each visit (Each one plam is equivalent to 1% of BSA). Photographs will be taken .
Efficacy of treatment 6 months post treatment The area of vitiligo will be measured using body surface area (BSA). the difference in BSA will represent the improvement from baseline. Patient palm will be used for estimation of BSA at each visit (Each one plam is equivalent to 1% of BSA). Photographs will be taken.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Diala Alshiyab
🇯🇴Irbid, Jordan